PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
-0.06%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.32B
AUM Growth
+$1.32B
(+2.8%)
Cap. Flow
+$65M
Cap. Flow
% of AUM
4.91%
Top 10 Holdings %
Top 10 Hldgs %
68.37%
Holding
46
New
2
Increased
28
Reduced
2
Closed
1
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$39.6M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$30.9M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$30.9M |
| 4 |
CEMP
Cempra, Inc.
CEMP
|
$25.9M |
| 5 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
$22.3M |
Top Sells
| 1 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$119M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
$28.3M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$15.2M |
Sector Composition
| 1 | Healthcare | 90.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $226M | 17.06% | 2,066,919 -259,040 | -11% | -$28.3M |
|
2
United Therapeutics
UTHR
$13.8B
| $182M | 13.75% | 1,718,658 +193,004 | +13% | +$20.4M |
|
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $135M | 10.21% | 1,737,399 +397,052 | +30% | +$30.9M |
|
|
AMAG
4
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $78.3M | 5.91% | 3,273,220 +367,026 | +13% | +$8.78M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $52.2M | 3.94% | 3,804,088 +342,723 | +10% | +$4.7M |
|
6
Insmed
INSM
$28.8B
| $49.8M | 3.76% | 5,054,713 +263,913 | +6% | +$2.6M |
|
7
Vanda Pharmaceuticals
VNDA
$279M
| $47.3M | 3.57% | 4,225,608 +194,700 | +5% | +$2.18M |
|
|
8
Acadia Pharmaceuticals
ACAD
$4.38B
| $46.7M | 3.53% | 1,437,730 +952,630 | +196% | +$30.9M |
|
|
CEMP
9
DELISTED
Cempra, Inc.
CEMP
| $46M | 3.47% | 2,787,542 +1,571,709 | +129% | +$25.9M |
|
|
WMGI
10
DELISTED
Wright Medical Group Inc
WMGI
| $41.8M | 3.16% | 2,408,393 +217,436 | +10% | +$3.78M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $39.6M | 2.99% | +339,400 | New | +$39.6M |
|
|
ZLTQ
12
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $38M | 2.87% | 1,391,079 +817,443 | +143% | +$22.3M |
|
|
EPZM
13
DELISTED
Epizyme, Inc
EPZM
| $27.8M | 2.1% | 2,711,381 +55,902 | +2% | +$572K |
|
|
CELG
14
DELISTED
Celgene Corp
CELG
| $27.6M | 2.08% | 279,600 +8,800 | +3% | +$868K |
|
15
Prothena Corp
PRTA
$441M
| $27.6M | 2.08% | 788,618 +93,100 | +13% | +$3.25M |
|
16
Gilead Sciences
GILD
$140B
| $26.6M | 2.01% | 318,400 +15,500 | +5% | +$1.29M |
|
|
SHPG
17
DELISTED
Shire pic
SHPG
| $22M | 1.66% | 119,300 +13,200 | +12% | +$2.43M |
|
18
Amicus Therapeutics
FOLD
$2.34B
| $21.9M | 1.65% | 4,009,375 +458,202 | +13% | +$2.5M |
|
19
Karyopharm Therapeutics
KPTI
$61.7M
| $21.1M | 1.59% | 3,139,433 +41,288 | +1% | +$277K |
|
|
ARIA
20
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $18.7M | 1.42% | 2,535,117 +286,800 | +13% | +$2.12M |
|
21
STAAR Surgical
STAA
$1.36B
| $17.7M | 1.33% | 3,207,210 +565,335 | +21% | +$3.12M |
|
|
MNTA
22
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $17.6M | 1.33% | 1,629,076 +160,300 | +11% | +$1.73M |
|
|
MDVN
23
DELISTED
MEDIVATION, INC.
MDVN
| $16.5M | 1.25% | 273,983 -251,479 | -48% | -$15.2M |
|
|
HTWR
24
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $15.8M | 1.19% | 272,986 +21,118 | +8% | +$1.22M |
|
|
ENDP
25
DELISTED
Endo International plc
ENDP
| $14.4M | 1.09% | 923,230 +94,600 | +11% | +$1.47M |
|